The earlier that cancer can be found, the better the chance it can be successfully treated.
The STRIVE Study is supporting the development of a new tool for early cancer detection that finds small pieces of genomic material coming from cancer allowing for early cancer detection.
Study follow-up involves collecting information from participants to confirm their health status. STRIVE research teams at participating locations will be reaching out to participants occasionally to collect follow-up information. Each follow-up contact will only take about 5 minutes of your time. Study researchers will also be actively monitoring electronic health records for up to 5 years from the date of enrollment to capture clinical outcome data, including cancer diagnoses.
You will not receive any personal test results because this is a research study and the test is still under development.